Metabolism


Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
A5384 Zileuton1 CitationSummary: 5-lipoxygenase (5-LOX) inhibitor, orally active -
B5697 WIN 18446Summary: inhibitor of aldehyde dehydrogenase 1a2 (ALDH1a2) -
C5183 IbudilastSummary: inhibitor of PDE4 -
B1943 Fenofibrate1 CitationSummary: PPARα agonist -
B1947 GemfibrozilSummary: PPARα activator -
B6371 (±)-Octanoylcarnitine chloride5 CitationSummary: an intermediate in fatty acid metabolism -
B5462 Rotenone10 CitationTarget: complex I of the mitochondrial electron transport chainSummary: mitochondrial Complex I inhibitor -
A4302 Rosiglitazone maleateTarget: Insulin and Insulin-like ReceptorsSummary: PPARγ agonist,high-affinity and selective,potent insulin sensitizer -
A3893 TroglitazoneTarget: PPARSummary: Selective PPARγ agonist -
C5081 Bromoenol lactoneSummary: Inhibitor of myocardial cytosolic calcium-independent phospholipase A2 (iPLA2)

